Skip to main content
Top
Published in: BMC Infectious Diseases 1/2012

Open Access 01-12-2012 | Research article

Role of Helicobacter pylori cagA EPIYA motif and vacAgenotypes for the development of gastrointestinal diseases in Southeast Asian countries: a meta-analysis

Authors: Shu Sahara, Mitsushige Sugimoto, Ratha-Korn Vilaichone, Varocha Mahachai, Hiroaki Miyajima, Takahisa Furuta, Yoshio Yamaoka

Published in: BMC Infectious Diseases | Issue 1/2012

Login to get access

Abstract

Background

Infection with cagA-positive, cagA EPIYA motif ABD type, and vacA s1, m1, and i1 genotype strains of Helicobacter pylori is associated with an exacerbated inflammatory response and increased risk of gastroduodenal diseases. However, it is unclear whether the prevalence and virulence factor genotypes found in Southeast Asia are similar to those in Western countries. Here, we examined the cagA status and prevalence of cagA EPIYA motifs and vacA genotypes among H. pylori strains found in Southeast Asia and examined their association with gastroduodenal disease.

Methods

To determine the cagA status, cagA EPIYA motifs, and vacA genotypes of H. pylori, we conducted meta-analyses of 13 previous reports for 1,281 H. pylori strains detected from several Southeast Asian countries.

Results

The respective frequencies of cagA-positive and vacA s1, m1, and i1 genotypes among examined subjects were 93% (1,056/1,133), 98% (1,010/1,033), 58% (581/1,009), and 96% (248/259), respectively. Stratification showed significant variation in the frequencies of cagA status and vacA genotypes among countries and the individual races residing within each respective country. The frequency of the vacA m-region genotype in patients infected with East Asian-type strains differed significantly between the northern and southern areas of Vietnam (p < 0.001). Infection with vacA m1 type or cagA-positive strains was associated with an increased risk of peptic ulcer disease (odds ratio: 1.46, 95%CI: 1.01-2.12, p = 0.046 and 2.83, 1.50-5.34, p = 0.001, respectively) in the examined Southeast Asian populations.

Conclusions

Both Western- and East Asian-type strains of H. pylori are found in Southeast Asia and are predominantly cagA-positive and vacA s1 type. In Southeast Asia, patients infected with vacA m1 type or cagA-positive strains have an increased risk of peptic ulcer disease. Thus, testing for this genotype and the presence of cagA may have clinical usefulness.
Appendix
Available only for authorised users
Literature
1.
go back to reference Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ: Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001, 345 (11): 784-789. 10.1056/NEJMoa001999.CrossRefPubMed Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ: Helicobacter pylori infection and the development of gastric cancer. N Engl J Med. 2001, 345 (11): 784-789. 10.1056/NEJMoa001999.CrossRefPubMed
2.
go back to reference Hopkins RJ, Girardi LS, Turney EA: Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: a review. Gastroenterology. 1996, 110 (4): 1244-1252. 10.1053/gast.1996.v110.pm8613015.CrossRefPubMed Hopkins RJ, Girardi LS, Turney EA: Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence: a review. Gastroenterology. 1996, 110 (4): 1244-1252. 10.1053/gast.1996.v110.pm8613015.CrossRefPubMed
3.
go back to reference Wotherspoon AC, Doglioni C, De Boni M, Spencer J, Isaacson PG: Antibiotic treatment for low-grade gastric malt lymphoma. Lancet. 1994, 343 (8911): 1503-10.1016/S0140-6736(94)92613-1.CrossRefPubMed Wotherspoon AC, Doglioni C, De Boni M, Spencer J, Isaacson PG: Antibiotic treatment for low-grade gastric malt lymphoma. Lancet. 1994, 343 (8911): 1503-10.1016/S0140-6736(94)92613-1.CrossRefPubMed
4.
go back to reference Fukase K, Kato M, Kikuchi S, Inoue K, Uemura N, Okamoto S, Terao S, Amagai K, Hayashi S, Asaka M: Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet. 2008, 372 (9636): 392-397. 10.1016/S0140-6736(08)61159-9.CrossRefPubMed Fukase K, Kato M, Kikuchi S, Inoue K, Uemura N, Okamoto S, Terao S, Amagai K, Hayashi S, Asaka M: Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet. 2008, 372 (9636): 392-397. 10.1016/S0140-6736(08)61159-9.CrossRefPubMed
5.
go back to reference Perez-Perez GI, Taylor DN, Bodhidatta L, Wongsrichanalai J, Baze WB, Dunn BE, Echeverria PD, Blaser MJ: Seroprevalence of Helicobacter pylori infections in Thailand. J Infect Dis. 1990, 161 (6): 1237-1241. 10.1093/infdis/161.6.1237.CrossRefPubMed Perez-Perez GI, Taylor DN, Bodhidatta L, Wongsrichanalai J, Baze WB, Dunn BE, Echeverria PD, Blaser MJ: Seroprevalence of Helicobacter pylori infections in Thailand. J Infect Dis. 1990, 161 (6): 1237-1241. 10.1093/infdis/161.6.1237.CrossRefPubMed
6.
go back to reference Rocha GA, Queiroz DM, Mendes EN, Oliveira AM, Moura SB, Barbosa MT, Mendes CC, Lima Junior GF, Oliveira CA: Indirect immunofluorescence determination of the frequency of anti-H pylori antibodies in brazilian blood donors. Braz J Med Biol Res. 1992, 25 (7): 683-689.PubMed Rocha GA, Queiroz DM, Mendes EN, Oliveira AM, Moura SB, Barbosa MT, Mendes CC, Lima Junior GF, Oliveira CA: Indirect immunofluorescence determination of the frequency of anti-H pylori antibodies in brazilian blood donors. Braz J Med Biol Res. 1992, 25 (7): 683-689.PubMed
7.
go back to reference Yamaoka Y, Orito E, Mizokami M, Gutierrez O, Saitou N, Kodama T, Osato MS, Kim JG, Ramirez FC, Mahachai V, et al: Helicobacter pylori in north and south america before columbus. FEBS Lett. 2002, 517 (1–3): 180-184.CrossRefPubMed Yamaoka Y, Orito E, Mizokami M, Gutierrez O, Saitou N, Kodama T, Osato MS, Kim JG, Ramirez FC, Mahachai V, et al: Helicobacter pylori in north and south america before columbus. FEBS Lett. 2002, 517 (1–3): 180-184.CrossRefPubMed
8.
go back to reference Van Doorn LJ, Schneeberger PM, Nouhan N, Plaisier AP, Quint WG, De Boer WA: Importance of Helicobacter pylori caga and vacA status for the efficacy of antibiotic treatment. Gut. 2000, 46 (3): 321-326. 10.1136/gut.46.3.321.CrossRefPubMedPubMedCentral Van Doorn LJ, Schneeberger PM, Nouhan N, Plaisier AP, Quint WG, De Boer WA: Importance of Helicobacter pylori caga and vacA status for the efficacy of antibiotic treatment. Gut. 2000, 46 (3): 321-326. 10.1136/gut.46.3.321.CrossRefPubMedPubMedCentral
9.
go back to reference Sugimoto M, Yamaoka Y: The association of vacA genotype and Helicobacter pylori-related disease in latin american and african populations. Clin Microbiol Infect. 2009, 15 (9): 835-842. 10.1111/j.1469-0691.2009.02769.x.CrossRefPubMedPubMedCentral Sugimoto M, Yamaoka Y: The association of vacA genotype and Helicobacter pylori-related disease in latin american and african populations. Clin Microbiol Infect. 2009, 15 (9): 835-842. 10.1111/j.1469-0691.2009.02769.x.CrossRefPubMedPubMedCentral
10.
go back to reference Sugimoto M, Zali MR, Yamaoka Y: The association of vacA genotypes and Helicobacter pylori-related gastroduodenal diseases in the Middle East. Eur J Clin Microbiol Infect Dis. 2009, 28 (10): 1227-1236. 10.1007/s10096-009-0772-y.CrossRefPubMedPubMedCentral Sugimoto M, Zali MR, Yamaoka Y: The association of vacA genotypes and Helicobacter pylori-related gastroduodenal diseases in the Middle East. Eur J Clin Microbiol Infect Dis. 2009, 28 (10): 1227-1236. 10.1007/s10096-009-0772-y.CrossRefPubMedPubMedCentral
11.
go back to reference Matsukura N, Yamada S, Kato S, Tomtitchong P, Tajiri T, Miki M, Matsuhisa T, Yamada N: Genetic differences in interleukin-1 beta polymorphisms among four asian populations: an analysis of the Asian paradox between h. pylori infection and gastric cancer incidence. J Exp Clin Cancer Res. 2003, 22 (1): 47-55.PubMed Matsukura N, Yamada S, Kato S, Tomtitchong P, Tajiri T, Miki M, Matsuhisa T, Yamada N: Genetic differences in interleukin-1 beta polymorphisms among four asian populations: an analysis of the Asian paradox between h. pylori infection and gastric cancer incidence. J Exp Clin Cancer Res. 2003, 22 (1): 47-55.PubMed
12.
go back to reference Yamada S, Matsuhisa T, Makonkawkeyoon L, Chaidatch S, Kato S, Matsukura N: Helicobacter pylori infection in combination with the serum pepsinogen I/II ratio and interleukin-1beta-511 polymorphisms are independent risk factors for gastric cancer in thais. J Gastroenterol. 2006, 41 (12): 1169-1177.CrossRefPubMed Yamada S, Matsuhisa T, Makonkawkeyoon L, Chaidatch S, Kato S, Matsukura N: Helicobacter pylori infection in combination with the serum pepsinogen I/II ratio and interleukin-1beta-511 polymorphisms are independent risk factors for gastric cancer in thais. J Gastroenterol. 2006, 41 (12): 1169-1177.CrossRefPubMed
13.
go back to reference Lunet N, Barros H: Helicobacter pylori infection and gastric cancer: facing the enigmas. Int J Cancer. 2003, 106 (6): 953-960. 10.1002/ijc.11306.CrossRefPubMed Lunet N, Barros H: Helicobacter pylori infection and gastric cancer: facing the enigmas. Int J Cancer. 2003, 106 (6): 953-960. 10.1002/ijc.11306.CrossRefPubMed
14.
go back to reference Miwa H, Go MF, N S: H. pylori and gastric cancer: the Asian enigma. Am J Gastroenterol. 2002, 97 (5): 1106-1112. 10.1111/j.1572-0241.2002.05663.x.CrossRefPubMed Miwa H, Go MF, N S: H. pylori and gastric cancer: the Asian enigma. Am J Gastroenterol. 2002, 97 (5): 1106-1112. 10.1111/j.1572-0241.2002.05663.x.CrossRefPubMed
15.
go back to reference Yamaoka Y, Kodama T, Gutierrez O, Kim JG, Kashima K, Graham DY: Relationship between Helicobacter pylori iceA, cagA and vacA status and clinical outcome: studies in four different countries. J Clin Microbiol. 1999, 37 (7): 2274-2279.PubMedPubMedCentral Yamaoka Y, Kodama T, Gutierrez O, Kim JG, Kashima K, Graham DY: Relationship between Helicobacter pylori iceA, cagA and vacA status and clinical outcome: studies in four different countries. J Clin Microbiol. 1999, 37 (7): 2274-2279.PubMedPubMedCentral
16.
go back to reference Yamaoka Y, Kikuchi S, el-Zimaity HM, Gutierrez O, Osato MS, Graham DY: Importance of Helicobacter pylori oipa in clinical presentation, gastric inflammation, and mucosal interleukin 8 production. Gastroenterology. 2002, 123 (2): 414-424. 10.1053/gast.2002.34781.CrossRefPubMed Yamaoka Y, Kikuchi S, el-Zimaity HM, Gutierrez O, Osato MS, Graham DY: Importance of Helicobacter pylori oipa in clinical presentation, gastric inflammation, and mucosal interleukin 8 production. Gastroenterology. 2002, 123 (2): 414-424. 10.1053/gast.2002.34781.CrossRefPubMed
17.
go back to reference Covacci A, Telford JL, Del Giudice G, Parsonnet J, Rappuoli R: Helicobacter pylori virulence and genetic geography. Science. 1999, 284 (5418): 1328-1333. 10.1126/science.284.5418.1328.CrossRefPubMed Covacci A, Telford JL, Del Giudice G, Parsonnet J, Rappuoli R: Helicobacter pylori virulence and genetic geography. Science. 1999, 284 (5418): 1328-1333. 10.1126/science.284.5418.1328.CrossRefPubMed
18.
go back to reference Higashi H, Tsutsumi R, Muto S, Sugiyama T, Azuma T, Asaka M, Hatakeyama M: Shp-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori cagA protein. Science. 2002, 295 (5555): 683-686. 10.1126/science.1067147.CrossRefPubMed Higashi H, Tsutsumi R, Muto S, Sugiyama T, Azuma T, Asaka M, Hatakeyama M: Shp-2 tyrosine phosphatase as an intracellular target of Helicobacter pylori cagA protein. Science. 2002, 295 (5555): 683-686. 10.1126/science.1067147.CrossRefPubMed
19.
go back to reference Broutet N, Tchamgoue S, Pereira E, Lamouliatte H, Salamon R, Megraud F: Risk factors for failure of Helicobacter pylori therapy–results of an individual data analysis of 2751 patients. Aliment Pharmacol Ther. 2003, 17 (1): 99-109. 10.1046/j.1365-2036.2003.01396.x.CrossRefPubMed Broutet N, Tchamgoue S, Pereira E, Lamouliatte H, Salamon R, Megraud F: Risk factors for failure of Helicobacter pylori therapy–results of an individual data analysis of 2751 patients. Aliment Pharmacol Ther. 2003, 17 (1): 99-109. 10.1046/j.1365-2036.2003.01396.x.CrossRefPubMed
20.
go back to reference van der Hulst RW, Weel JF, Verheul SB, Keller JJ, ten Kate FJ, van der Ende A, Rauws EA, Dankert J, Tytgat GN: Treatment of Helicobacter pylori infection with low or high dose omeprazole combined with amoxycillin and the effect of early retreatment. Aliment Pharmacol Ther. 1996, 10 (2): 165-171. 10.1046/j.1365-2036.1996.715895000.x.CrossRefPubMed van der Hulst RW, Weel JF, Verheul SB, Keller JJ, ten Kate FJ, van der Ende A, Rauws EA, Dankert J, Tytgat GN: Treatment of Helicobacter pylori infection with low or high dose omeprazole combined with amoxycillin and the effect of early retreatment. Aliment Pharmacol Ther. 1996, 10 (2): 165-171. 10.1046/j.1365-2036.1996.715895000.x.CrossRefPubMed
21.
go back to reference Yamaoka Y, El-Zimaity HM, Gutierrez O, Figura N, Kim JG, Kodama T, Kashima K, Graham DY: Relationship between the cagA 3' repeat region of Helicobacter pylori, gastric histology, and susceptibility to low pH. Gastroenterology. 1999, 117 (2): 342-349. 10.1053/gast.1999.0029900342.CrossRefPubMed Yamaoka Y, El-Zimaity HM, Gutierrez O, Figura N, Kim JG, Kodama T, Kashima K, Graham DY: Relationship between the cagA 3' repeat region of Helicobacter pylori, gastric histology, and susceptibility to low pH. Gastroenterology. 1999, 117 (2): 342-349. 10.1053/gast.1999.0029900342.CrossRefPubMed
22.
go back to reference Higashi H, Tsutsumi R, Fujita A, Yamazaki S, Asaka M, Azuma T, Hatakeyama M: Biological activity of the Helicobacter pylori virulence factor cagA is determined by variation in the tyrosine phosphorylation sites. Proc Natl Acad Sci U S A. 2002, 99 (22): 14428-14433. 10.1073/pnas.222375399.CrossRefPubMedPubMedCentral Higashi H, Tsutsumi R, Fujita A, Yamazaki S, Asaka M, Azuma T, Hatakeyama M: Biological activity of the Helicobacter pylori virulence factor cagA is determined by variation in the tyrosine phosphorylation sites. Proc Natl Acad Sci U S A. 2002, 99 (22): 14428-14433. 10.1073/pnas.222375399.CrossRefPubMedPubMedCentral
23.
go back to reference Selbach M, Moese S, Hauck CR, Meyer TF, Backert S: Src is the kinase of the Helicobacter pylori caga protein in vitro and in vivo. J Biol Chem. 2002, 277 (9): 6775-6778. 10.1074/jbc.C100754200.CrossRefPubMed Selbach M, Moese S, Hauck CR, Meyer TF, Backert S: Src is the kinase of the Helicobacter pylori caga protein in vitro and in vivo. J Biol Chem. 2002, 277 (9): 6775-6778. 10.1074/jbc.C100754200.CrossRefPubMed
24.
go back to reference Backert S, Moese S, Selbach M, Brinkmann V, Meyer TF: Phosphorylation of tyrosine 972 of the Helicobacter pylori cagA protein is essential for induction of a scattering phenotype in gastric epithelial cells. Mol Microbiol. 2001, 42 (3): 631-644.CrossRefPubMed Backert S, Moese S, Selbach M, Brinkmann V, Meyer TF: Phosphorylation of tyrosine 972 of the Helicobacter pylori cagA protein is essential for induction of a scattering phenotype in gastric epithelial cells. Mol Microbiol. 2001, 42 (3): 631-644.CrossRefPubMed
25.
go back to reference Atherton JC, Cao P, Peek RM, Tummuru MK, Blaser MJ, Cover TL: Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem. 1995, 270 (30): 17771-17777. 10.1074/jbc.270.30.17771.CrossRefPubMed Atherton JC, Cao P, Peek RM, Tummuru MK, Blaser MJ, Cover TL: Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem. 1995, 270 (30): 17771-17777. 10.1074/jbc.270.30.17771.CrossRefPubMed
26.
go back to reference Rhead JL, Letley DP, Mohammadi M, Hussein N, Mohagheghi MA, Eshagh Hosseini M, Atherton JC: A new Helicobacter pylori vacuolating cytotoxin determinant, the intermediate region, is associated with gastric cancer. Gastroenterology. 2007, 133 (3): 926-936. 10.1053/j.gastro.2007.06.056.CrossRefPubMed Rhead JL, Letley DP, Mohammadi M, Hussein N, Mohagheghi MA, Eshagh Hosseini M, Atherton JC: A new Helicobacter pylori vacuolating cytotoxin determinant, the intermediate region, is associated with gastric cancer. Gastroenterology. 2007, 133 (3): 926-936. 10.1053/j.gastro.2007.06.056.CrossRefPubMed
27.
go back to reference Kidd M, Lastovica AJ, Atherton JC, Louw JA: Heterogeneity in the Helicobacter pylori vacA and cagA genes: association with gastroduodenal disease in South Africa?. Gut. 1999, 45 (4): 499-502. 10.1136/gut.45.4.499.CrossRefPubMedPubMedCentral Kidd M, Lastovica AJ, Atherton JC, Louw JA: Heterogeneity in the Helicobacter pylori vacA and cagA genes: association with gastroduodenal disease in South Africa?. Gut. 1999, 45 (4): 499-502. 10.1136/gut.45.4.499.CrossRefPubMedPubMedCentral
28.
go back to reference Miehlke S, Kirsch C, Agha-Amiri K, Gunther T, Lehn N, Malfertheiner P, Stolte M, Ehninger G, Bayerdorffer E: The Helicobacter pylori vacA s1, m1 genotype and cagA is associated with gastric carcinoma in germany. Int J Cancer. 2000, 87 (3): 322-327. 10.1002/1097-0215(20000801)87:3<322::AID-IJC3>3.0.CO;2-M.CrossRefPubMed Miehlke S, Kirsch C, Agha-Amiri K, Gunther T, Lehn N, Malfertheiner P, Stolte M, Ehninger G, Bayerdorffer E: The Helicobacter pylori vacA s1, m1 genotype and cagA is associated with gastric carcinoma in germany. Int J Cancer. 2000, 87 (3): 322-327. 10.1002/1097-0215(20000801)87:3<322::AID-IJC3>3.0.CO;2-M.CrossRefPubMed
29.
go back to reference Figueiredo C, Van Doorn LJ, Nogueira C, Soares JM, Pinho C, Figueira P, Quint WG, Carneiro F: Helicobacter pylori genotypes are associated with clinical outcome in portuguese patients and show a high prevalence of infections with multiple strains. Scand J Gastroenterol. 2001, 36 (2): 128-135.CrossRefPubMed Figueiredo C, Van Doorn LJ, Nogueira C, Soares JM, Pinho C, Figueira P, Quint WG, Carneiro F: Helicobacter pylori genotypes are associated with clinical outcome in portuguese patients and show a high prevalence of infections with multiple strains. Scand J Gastroenterol. 2001, 36 (2): 128-135.CrossRefPubMed
30.
go back to reference Atherton JC, Peek RM, Tham KT, Cover TL, Blaser MJ: Clinical and pathological importance of heterogeneity in vacA, the vacuolating cytotoxin gene of Helicobacter pylori. Gastroenterology. 1997, 112 (1): 92-99. 10.1016/S0016-5085(97)70223-3.CrossRefPubMed Atherton JC, Peek RM, Tham KT, Cover TL, Blaser MJ: Clinical and pathological importance of heterogeneity in vacA, the vacuolating cytotoxin gene of Helicobacter pylori. Gastroenterology. 1997, 112 (1): 92-99. 10.1016/S0016-5085(97)70223-3.CrossRefPubMed
31.
go back to reference Uchida T, Nguyen LT, Takayama A, Okimoto T, Kodama M, Murakami K, Matsuhisa T, Trinh TD, Ta L, Ho DQ, et al: Analysis of virulence factors of Helicobacter pylori isolated from a vietnamese population. BMC Microbiol. 2009, 9: 175-10.1186/1471-2180-9-175.CrossRefPubMedPubMedCentral Uchida T, Nguyen LT, Takayama A, Okimoto T, Kodama M, Murakami K, Matsuhisa T, Trinh TD, Ta L, Ho DQ, et al: Analysis of virulence factors of Helicobacter pylori isolated from a vietnamese population. BMC Microbiol. 2009, 9: 175-10.1186/1471-2180-9-175.CrossRefPubMedPubMedCentral
32.
go back to reference Truong BX, Mai VT, Tanaka H, le Ly T, Thong TM, Hai HH, Van Long D, Furumatsu K, Yoshida M, Kutsumi H, et al: Diverse characteristics of the cagA gene of Helicobacter pylori strains collected from patients from South Vietnam with gastric cancer and peptic ulcer. J Clin Microbiol. 2009, 47 (12): 4021-4028. 10.1128/JCM.00504-09.CrossRefPubMedPubMedCentral Truong BX, Mai VT, Tanaka H, le Ly T, Thong TM, Hai HH, Van Long D, Furumatsu K, Yoshida M, Kutsumi H, et al: Diverse characteristics of the cagA gene of Helicobacter pylori strains collected from patients from South Vietnam with gastric cancer and peptic ulcer. J Clin Microbiol. 2009, 47 (12): 4021-4028. 10.1128/JCM.00504-09.CrossRefPubMedPubMedCentral
33.
go back to reference Nguyen TL, Uchida T, Tsukamoto Y, Trinh DT, Ta L, Mai BH, Le SH, Thai KD, Ho DD, Hoang HH, et al: Helicobacter pylori infection and gastroduodenal diseases in Vietnam: a cross-sectional, hospital-based study. BMC Gastroenterol. 2010, 10: 114-10.1186/1471-230X-10-114.CrossRefPubMedPubMedCentral Nguyen TL, Uchida T, Tsukamoto Y, Trinh DT, Ta L, Mai BH, Le SH, Thai KD, Ho DD, Hoang HH, et al: Helicobacter pylori infection and gastroduodenal diseases in Vietnam: a cross-sectional, hospital-based study. BMC Gastroenterol. 2010, 10: 114-10.1186/1471-230X-10-114.CrossRefPubMedPubMedCentral
34.
go back to reference Vilaichone RK, Mahachai V, Tumwasorn S, Wu JY, Graham DY, Yamaoka Y: Molecular epidemiology and outcome of Helicobacter pylori infection in Thailand: a cultural cross roads. Helicobacter. 2004, 9 (5): 453-459. 10.1111/j.1083-4389.2004.00260.x.CrossRefPubMed Vilaichone RK, Mahachai V, Tumwasorn S, Wu JY, Graham DY, Yamaoka Y: Molecular epidemiology and outcome of Helicobacter pylori infection in Thailand: a cultural cross roads. Helicobacter. 2004, 9 (5): 453-459. 10.1111/j.1083-4389.2004.00260.x.CrossRefPubMed
35.
go back to reference Linpisarn S, Suwan W, Lertprasertsuk N, Koosirirat C, Steger HF, Prommuangyong K, Phornphutkul K: Helicobacter pylori cagA, vacA and iceA genotypes in Northern Thai patients with gastric disease. Southeast Asian J Trop Med Public Health. 2007, 38 (2): 356-362.PubMed Linpisarn S, Suwan W, Lertprasertsuk N, Koosirirat C, Steger HF, Prommuangyong K, Phornphutkul K: Helicobacter pylori cagA, vacA and iceA genotypes in Northern Thai patients with gastric disease. Southeast Asian J Trop Med Public Health. 2007, 38 (2): 356-362.PubMed
36.
go back to reference Chomvarin C, Namwat W, Chaicumpar K, Mairiang P, Sangchan A, Sripa B, Tor-Udom S, Vilaichone RK: Prevalence of Helicobacter pylori vacA, cagA, cagE, iceA and baba2 genotypes in thai dyspeptic patients. Int J Infect Dis. 2008, 12 (1): 30-36. 10.1016/j.ijid.2007.03.012.CrossRefPubMed Chomvarin C, Namwat W, Chaicumpar K, Mairiang P, Sangchan A, Sripa B, Tor-Udom S, Vilaichone RK: Prevalence of Helicobacter pylori vacA, cagA, cagE, iceA and baba2 genotypes in thai dyspeptic patients. Int J Infect Dis. 2008, 12 (1): 30-36. 10.1016/j.ijid.2007.03.012.CrossRefPubMed
37.
go back to reference Tan HJ, Rizal AM, Rosmadi MY, Goh KL: Distribution of Helicobacter pylori cagA, cagE and vacA in different ethnic groups in Kuala Lumpur, Malaysia. J Gastroenterol Hepatol. 2005, 20 (4): 589-594. 10.1111/j.1440-1746.2005.03783.x.CrossRefPubMed Tan HJ, Rizal AM, Rosmadi MY, Goh KL: Distribution of Helicobacter pylori cagA, cagE and vacA in different ethnic groups in Kuala Lumpur, Malaysia. J Gastroenterol Hepatol. 2005, 20 (4): 589-594. 10.1111/j.1440-1746.2005.03783.x.CrossRefPubMed
38.
go back to reference Tan HJ, Rizal AM, Rosmadi MY, Goh KL: Role of Helicobacter pylori virulence factor and genotypes in non-ulcer dyspepsia. J Gastroenterol Hepatol. 2006, 21 (1 Pt 1): 110-115.CrossRefPubMed Tan HJ, Rizal AM, Rosmadi MY, Goh KL: Role of Helicobacter pylori virulence factor and genotypes in non-ulcer dyspepsia. J Gastroenterol Hepatol. 2006, 21 (1 Pt 1): 110-115.CrossRefPubMed
39.
go back to reference Mohamed R, Hanafiah A, Rose IM, Manaf MR, Abdullah SA, Sagap I, Van Belkum A, Yaacob JA: Helicobacter pylori cagA gene variants in malaysians of different ethnicity. Eur J Clin Microbiol Infect Dis. 2009, 28 (7): 865-869. 10.1007/s10096-009-0712-x.CrossRefPubMedPubMedCentral Mohamed R, Hanafiah A, Rose IM, Manaf MR, Abdullah SA, Sagap I, Van Belkum A, Yaacob JA: Helicobacter pylori cagA gene variants in malaysians of different ethnicity. Eur J Clin Microbiol Infect Dis. 2009, 28 (7): 865-869. 10.1007/s10096-009-0712-x.CrossRefPubMedPubMedCentral
40.
go back to reference Schmidt HM, Goh KL, Fock KM, Hilmi I, Dhamodaran S, Forman D, Mitchell H: Distinct cagA EPIYA motifs are associated with ethnic diversity in Malaysia and Singapore. Helicobacter. 2009, 14 (4): 256-263. 10.1111/j.1523-5378.2009.00684.x.CrossRefPubMed Schmidt HM, Goh KL, Fock KM, Hilmi I, Dhamodaran S, Forman D, Mitchell H: Distinct cagA EPIYA motifs are associated with ethnic diversity in Malaysia and Singapore. Helicobacter. 2009, 14 (4): 256-263. 10.1111/j.1523-5378.2009.00684.x.CrossRefPubMed
41.
go back to reference Schmidt HM, Andres S, Nilsson C, Kovach Z, Kaakoush NO, Engstrand L, Goh KL, Fock KM, Forman D, Mitchell H: The cagA PAI is intact and functional but hp0520 varies significantly in Helicobacter pylori isolates from Malaysia and Singapore. Eur J Clin Microbiol Infect Dis. 2010, 29 (4): 439-451. 10.1007/s10096-010-0881-7.CrossRefPubMed Schmidt HM, Andres S, Nilsson C, Kovach Z, Kaakoush NO, Engstrand L, Goh KL, Fock KM, Forman D, Mitchell H: The cagA PAI is intact and functional but hp0520 varies significantly in Helicobacter pylori isolates from Malaysia and Singapore. Eur J Clin Microbiol Infect Dis. 2010, 29 (4): 439-451. 10.1007/s10096-010-0881-7.CrossRefPubMed
42.
go back to reference Zheng PY, Hua J, Yeoh KG, Ho B: Association of peptic ulcer with increased expression of lewis antigens but not cagA, iceA, and vacA in Helicobacter pylori isolates in an Asian population. Gut. 2000, 47 (1): 18-22. 10.1136/gut.47.1.18.CrossRefPubMedPubMedCentral Zheng PY, Hua J, Yeoh KG, Ho B: Association of peptic ulcer with increased expression of lewis antigens but not cagA, iceA, and vacA in Helicobacter pylori isolates in an Asian population. Gut. 2000, 47 (1): 18-22. 10.1136/gut.47.1.18.CrossRefPubMedPubMedCentral
43.
go back to reference Van Doorn LJ, Figueiredo C, Sanna R, Plaisier A, Schneeberger P, De Boer W, Quint W: Clinical relevance of the cagA, vacA, and iceA status of Helicobacter pylori. Gastroenterology. 1998, 115 (1): 58-66. 10.1016/S0016-5085(98)70365-8.CrossRefPubMed Van Doorn LJ, Figueiredo C, Sanna R, Plaisier A, Schneeberger P, De Boer W, Quint W: Clinical relevance of the cagA, vacA, and iceA status of Helicobacter pylori. Gastroenterology. 1998, 115 (1): 58-66. 10.1016/S0016-5085(98)70365-8.CrossRefPubMed
44.
go back to reference Ho YW, Ho KY, Ascencio F, Ho B: Neither gastric topological distribution nor principle virulence genes of Helicobacter pylori contributes to clinical outcomes. World J Gastroenterol. 2004, 10 (22): 3274-3277.CrossRefPubMedPubMedCentral Ho YW, Ho KY, Ascencio F, Ho B: Neither gastric topological distribution nor principle virulence genes of Helicobacter pylori contributes to clinical outcomes. World J Gastroenterol. 2004, 10 (22): 3274-3277.CrossRefPubMedPubMedCentral
45.
go back to reference Vivatvakin B, Theamboonlers A, Semakachorn N, Wongsawadi L: Prevalence of cagA and vacA genotype of Helicobacter pylori in Thai children. J Med Assoc Thai. 2004, 87 (11): 1327-1331.PubMed Vivatvakin B, Theamboonlers A, Semakachorn N, Wongsawadi L: Prevalence of cagA and vacA genotype of Helicobacter pylori in Thai children. J Med Assoc Thai. 2004, 87 (11): 1327-1331.PubMed
46.
go back to reference Yamaoka Y, Malaty HM, Osato MS, Graham DY: Conservation of Helicobacter pylori genotypes in different ethnic groups in Houston, Texas. J Infect Dis. 2000, 181 (6): 2083-2086. 10.1086/315486.CrossRefPubMed Yamaoka Y, Malaty HM, Osato MS, Graham DY: Conservation of Helicobacter pylori genotypes in different ethnic groups in Houston, Texas. J Infect Dis. 2000, 181 (6): 2083-2086. 10.1086/315486.CrossRefPubMed
47.
go back to reference Ogiwara H, Sugimoto M, Ohno T, Vilaichone RK, Mahachai V, Graham DY, Yamaoka Y: Role of deletion located between intermediate- and middle-region of Helicobacter pylori vacA gene in gastroduodenal diseases. J Clin Microbiol. 2009, 47 (11): 3493-3500. 10.1128/JCM.00887-09.CrossRefPubMedPubMedCentral Ogiwara H, Sugimoto M, Ohno T, Vilaichone RK, Mahachai V, Graham DY, Yamaoka Y: Role of deletion located between intermediate- and middle-region of Helicobacter pylori vacA gene in gastroduodenal diseases. J Clin Microbiol. 2009, 47 (11): 3493-3500. 10.1128/JCM.00887-09.CrossRefPubMedPubMedCentral
48.
go back to reference Nogueira C, Figueiredo C, Carneiro F, Gomes AT, Barreira R, Figueira P, Salgado C, Belo L, Peixoto A, Bravo JC, et al: Helicobacter pylori genotypes may determine gastric histopathology. Am J Pathol. 2001, 158 (2): 647-654. 10.1016/S0002-9440(10)64006-0.CrossRefPubMedPubMedCentral Nogueira C, Figueiredo C, Carneiro F, Gomes AT, Barreira R, Figueira P, Salgado C, Belo L, Peixoto A, Bravo JC, et al: Helicobacter pylori genotypes may determine gastric histopathology. Am J Pathol. 2001, 158 (2): 647-654. 10.1016/S0002-9440(10)64006-0.CrossRefPubMedPubMedCentral
49.
go back to reference Martins LC, Corvelo TC, Demachki S, Araujo MT, Assumpcao MB, Vilar SC, Freitas FB, Barbosa HP, Fecury AA, do Amaral RK: Clinical and pathological importance of vacA allele heterogeneity and cagA status in peptic ulcer disease in patients from north brazil. Mem Inst Oswaldo Cruz. 2005, 100 (8): 875-881. 10.1590/S0074-02762005000800009.CrossRefPubMed Martins LC, Corvelo TC, Demachki S, Araujo MT, Assumpcao MB, Vilar SC, Freitas FB, Barbosa HP, Fecury AA, do Amaral RK: Clinical and pathological importance of vacA allele heterogeneity and cagA status in peptic ulcer disease in patients from north brazil. Mem Inst Oswaldo Cruz. 2005, 100 (8): 875-881. 10.1590/S0074-02762005000800009.CrossRefPubMed
50.
go back to reference Breurec S, Guillard B, Hem S, Brisse S, Dieye FB, Huerre M, Oung C, Raymond J, Tan TS, Thiberge JM, et al: Evolutionary history of Helicobacter pylori sequences reflect past human migrations in Southeast Asia. PLoS One. 2011, 6 (7): e22058-10.1371/journal.pone.0022058.CrossRefPubMedPubMedCentral Breurec S, Guillard B, Hem S, Brisse S, Dieye FB, Huerre M, Oung C, Raymond J, Tan TS, Thiberge JM, et al: Evolutionary history of Helicobacter pylori sequences reflect past human migrations in Southeast Asia. PLoS One. 2011, 6 (7): e22058-10.1371/journal.pone.0022058.CrossRefPubMedPubMedCentral
51.
go back to reference Higashi H, Yokoyama K, Fujii Y, Ren S, Yuasa H, Saadat I, Murata-Kamiya N, Azuma T, Hatakeyama M: EPIYA motif is a membrane-targeting signal of Helicobacter pylori virulence factor cagA in mammalian cells. J Biol Chem. 2005, 280 (24): 23130-23137. 10.1074/jbc.M503583200.CrossRefPubMed Higashi H, Yokoyama K, Fujii Y, Ren S, Yuasa H, Saadat I, Murata-Kamiya N, Azuma T, Hatakeyama M: EPIYA motif is a membrane-targeting signal of Helicobacter pylori virulence factor cagA in mammalian cells. J Biol Chem. 2005, 280 (24): 23130-23137. 10.1074/jbc.M503583200.CrossRefPubMed
52.
go back to reference Hatakeyama M: Oncogenic mechanisms of the Helicobacter pylori cagA protein. Nat Rev Cancer. 2004, 4 (9): 688-694. 10.1038/nrc1433.CrossRefPubMed Hatakeyama M: Oncogenic mechanisms of the Helicobacter pylori cagA protein. Nat Rev Cancer. 2004, 4 (9): 688-694. 10.1038/nrc1433.CrossRefPubMed
53.
go back to reference Yamaoka Y, Ojo O, Fujimoto S, Odenbreit S, Haas R, Gutierrez O, El-Zimaity HM, Reddy R, Arnqvist A, Graham DY: Helicobacter pylori outer membrane proteins and gastroduodenal disease. Gut. 2006, 55 (6): 775-781. 10.1136/gut.2005.083014.CrossRefPubMedPubMedCentral Yamaoka Y, Ojo O, Fujimoto S, Odenbreit S, Haas R, Gutierrez O, El-Zimaity HM, Reddy R, Arnqvist A, Graham DY: Helicobacter pylori outer membrane proteins and gastroduodenal disease. Gut. 2006, 55 (6): 775-781. 10.1136/gut.2005.083014.CrossRefPubMedPubMedCentral
54.
go back to reference Kersulyte D, Mukhopadhyay AK, Velapatino B, Su W, Pan Z, Garcia C, Hernandez V, Valdez Y, Mistry RS, Gilman RH, et al: Differences in genotypes of Helicobacter pylori from different human populations. J Bacteriol. 2000, 182 (11): 3210-3218. 10.1128/JB.182.11.3210-3218.2000.CrossRefPubMedPubMedCentral Kersulyte D, Mukhopadhyay AK, Velapatino B, Su W, Pan Z, Garcia C, Hernandez V, Valdez Y, Mistry RS, Gilman RH, et al: Differences in genotypes of Helicobacter pylori from different human populations. J Bacteriol. 2000, 182 (11): 3210-3218. 10.1128/JB.182.11.3210-3218.2000.CrossRefPubMedPubMedCentral
55.
go back to reference Vilaichone RK, Mahachai V, Tumwasorn S, Wu JY, Graham DY, Yamaoka Y: Gastric mucosal cytokine levels in relation to host interleukin-1 polymorphisms and Helicobacter pylori cagA genotype. Scand J Gastroenterol. 2005, 40 (5): 530-539. 10.1080/00365520510012299.CrossRefPubMed Vilaichone RK, Mahachai V, Tumwasorn S, Wu JY, Graham DY, Yamaoka Y: Gastric mucosal cytokine levels in relation to host interleukin-1 polymorphisms and Helicobacter pylori cagA genotype. Scand J Gastroenterol. 2005, 40 (5): 530-539. 10.1080/00365520510012299.CrossRefPubMed
56.
go back to reference Mueller D, Tegtmeyer N, Brandt S, Yamaoka Y, De Poire E, Sgouras D, Wessler S, Torres J, Smolka A, Backert S: C-src and c-abl kinases control hierarchic phosphorylation and function of the cagA effector protein in Western and East Asian Helicobacter pylori strains. J Clin Invest. 2012, 122 (4): 1553-1566. 10.1172/JCI61143.CrossRefPubMedPubMedCentral Mueller D, Tegtmeyer N, Brandt S, Yamaoka Y, De Poire E, Sgouras D, Wessler S, Torres J, Smolka A, Backert S: C-src and c-abl kinases control hierarchic phosphorylation and function of the cagA effector protein in Western and East Asian Helicobacter pylori strains. J Clin Invest. 2012, 122 (4): 1553-1566. 10.1172/JCI61143.CrossRefPubMedPubMedCentral
Metadata
Title
Role of Helicobacter pylori cagA EPIYA motif and vacAgenotypes for the development of gastrointestinal diseases in Southeast Asian countries: a meta-analysis
Authors
Shu Sahara
Mitsushige Sugimoto
Ratha-Korn Vilaichone
Varocha Mahachai
Hiroaki Miyajima
Takahisa Furuta
Yoshio Yamaoka
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2012
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-12-223

Other articles of this Issue 1/2012

BMC Infectious Diseases 1/2012 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.